197 related articles for article (PubMed ID: 6352237)
1. Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Sep; 26(3):212-29. PubMed ID: 6352237
[TBL] [Abstract][Full Text] [Related]
2. Comparative antihypertensive effects of guanabenz and methyldopa.
Walker BR; Deitch MW; Schneider BE; Hare LE
Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
[TBL] [Abstract][Full Text] [Related]
3. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
Rosendorff C
S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
[TBL] [Abstract][Full Text] [Related]
4. Guanabenz and methyldopa on hypertension and cardiac performance.
Walker BR; Shah RS; Ramanathan KB; Vanov SK; Helfant RH
Clin Pharmacol Ther; 1977 Dec; 22(6):868-74. PubMed ID: 336257
[TBL] [Abstract][Full Text] [Related]
5. Effect of guanabenz and hydrochlorothiazide on blood pressure and plasma renin activity.
Holland OB; Fairchild C; Gomez-Sanchez CE
J Clin Pharmacol; 1981 Apr; 21(4):133-9. PubMed ID: 7016928
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of guanabenz added to hydrochlorothiazide therapy in hypertension.
Walker BR; Deitch MW; Gold JA; Levey BA
J Int Med Res; 1982; 10(3):131-9. PubMed ID: 7047256
[TBL] [Abstract][Full Text] [Related]
7. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
Sorkin EM; Heel RC
Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
[TBL] [Abstract][Full Text] [Related]
8. Guanabenz in essential hypertension.
McMahon FG; Ryan JR; Jain AK; Vargas R; Vanov SK
Clin Pharmacol Ther; 1977 Mar; 21(3):272-7. PubMed ID: 319938
[TBL] [Abstract][Full Text] [Related]
9. Guanabenz for adolescent hypertension.
Walson PD; Rath A; Kilbourne K; Deitch MW
Pediatr Pharmacol (New York); 1984; 4(1):1-6. PubMed ID: 6739181
[TBL] [Abstract][Full Text] [Related]
10. Comparison of guanabenz and clonidine in hypertensive patients.
Kluyskens Y; Snoeck J
Curr Med Res Opin; 1980; 6(9):638-43. PubMed ID: 6996935
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of guanabenz versus clonidine.
Leary WP; Asmal AC; Williams PC
S Afr Med J; 1979 Jan; 55(3):83-5. PubMed ID: 371036
[TBL] [Abstract][Full Text] [Related]
12. Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertension.
Shah RS; Walker BR; Vanov SK; Helfant RH
Clin Pharmacol Ther; 1976 Jun; 19(6):732-7. PubMed ID: 773584
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapy of hypertension with guanabenz.
Walker BR; Deitch MW; Schneider BE; Hare LE; Gold JA
Clin Ther; 1981; 4(3):217-28. PubMed ID: 7307037
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic and water diuretic effects of guanabenz, a central alpha-2 agonist.
Goldberg M; Gehr M; MacCarthy EP
Trans Am Clin Climatol Assoc; 1984; 95():79-85. PubMed ID: 6679138
[TBL] [Abstract][Full Text] [Related]
15. Comparative antihypertensive effects of guanabenz and clonidine.
Walker BR; Hare LE; Deitch MW
J Int Med Res; 1982; 10(1):6-14. PubMed ID: 7037502
[TBL] [Abstract][Full Text] [Related]
16. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
Kawasaki H
Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic activity and conformation of the antihypertensive specific alpha 2-agonist drug, guanabenz.
Diamant S; Agranat I; Goldblum A; Cohen S; Atlas D
Biochem Pharmacol; 1985 Feb; 34(4):491-8. PubMed ID: 2857565
[TBL] [Abstract][Full Text] [Related]
18. Effect of guanabenz on blood pressure responses to posture and exercise.
Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of guanabenz: a new antihypertensive.
Bosanac P; Dubb J; Walker B; Goldberg M; Agus ZS
J Clin Pharmacol; 1976; 16(11-12):631-6. PubMed ID: 993358
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal syndrome following cessation of guanabenz therapy.
Ram CV; Holland OB; Fairchild C; Gomez-Sanchez CE
J Clin Pharmacol; 1979; 19(2-3):148-50. PubMed ID: 422739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
